Charles River Laboratories International, Inc. (CRL)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
3,688,047
3,540,160
2,923,933
2,621,226
2,266,096
Cost of revenue
2,310,164
2,205,522
1,850,392
1,662,915
1,426,029
Gross profit
1,377,883
1,334,638
1,073,541
958,311
840,067
Operating expenses
Selling general and administrative
574,429
619,919
528,935
517,622
443,854
Total operating expenses
713,085
744,776
640,812
607,160
508,684
Operating income or loss
664,798
589,862
432,729
351,151
331,383
Interest expense
41,138
73,910
86,433
60,882
63,772
Total other income/expenses net
-82,550
-35,894
99,984
12,293
13,258
Income before tax
541,871
480,710
447,114
304,084
281,681
Income tax expense
90,995
81,873
81,808
50,023
54,463
Income from continuing operations
450,876
398,837
365,306
254,061
227,218
Net income
443,347
390,982
364,304
252,019
226,373
Net income available to common shareholders
443,347
390,982
364,304
252,019
226,373
Basic EPS
-
7.77
7.35
5.17
4.72
Diluted EPS
-
7.60
7.20
5.07
4.62
Basic average shares
-
50,293
49,550
48,730
47,947
Diluted average shares
-
51,425
50,611
49,693
49,018
EBITDA
-
820,160
768,471
563,061
507,232
© 2022 Yahoo. All rights reserved.
